Rats treated as neonates with 6-hydroxydopamine are proposed to model
the dopamine deficiency associated with Lesch-Nyhan syndrome (LNS). To
understand the neurobiological basis of specific behaviors in LNS, in
vestigations were undertaken in these neonatally lesioned rats. Severa
l new findings resulted from these studies. The first was that D1-dopa
mine receptors are essential for the action of D2-dopamine receptors,
a phenomenon called ''coupling'' of receptor function. Another finding
was that D1-dopamine receptors must be repeatedly stimulated before m
aximal behavioral sensitivity can be observed. This has been referred
to as ''priming'' of D1-dopamine receptor responsiveness. This priming
action by repeated administration of a D1-dopamine agonist was antago
nized by NMDA antagonists indicating a potential role of glutamate in
this sensitization. Ongoing work suggests that DARPP-32 is not involve
d in priming of D1-dopamine receptor responsiveness. However, we have
observed an accumulation of GFAP in brain following repeated administr
ation of a D1-dopamine agonist. In addition, immunoblots employing an
antibody to phospho-DARPP-32 revealed a protein present in lesioned ra
t that was not present in control rats. Studies in these lesioned rats
are expected to continue to contribute to our basic understanding of
adaptive changes caused by lesioning of dopaminergic neurons during de
velopment. (C) 1994 Infox Press, Inc.